Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?

Research output: Contribution to journal › Letter

Original language	English
Journal	Clinical Infectious Diseases
Early online date	18 Sep 2020
DOIs	https://doi.org/10.1093/cid/ciaa1423
Publication status	E-pub ahead of print - 18 Sep 2020

Cite this

@article{9103d01193aa4982a4b8b8773ba1b29f,

title = "Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19?",

keywords = "COVID-19 Pandemic, Corticosteroids",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = sep,

day = "18",

doi = "10.1093/cid/ciaa1423",

language = "English",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Corticosteroid-related in-hospital hyperglycemia

T2 - does it negate mortality benefits in COVID-19?

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/9/18

Y1 - 2020/9/18

KW - COVID-19 Pandemic

KW - Corticosteroids

U2 - 10.1093/cid/ciaa1423

DO - 10.1093/cid/ciaa1423

M3 - Letter

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -